Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2026)

Nurix Therapeutics (NRIX) has reported Asset Utilization Ratio for 7 consecutive years, with 0.06 the latest figure, recorded in Q2 2026.

• In Q2 2026, Asset Utilization Ratio fell 57.16% year-over-year to 0.06; the TTM figure through May 2026 stood at 0.06 (down 57.16% YoY), while the FY2025 annual figure was 0.12, up 16.24% from the prior year.
• Asset Utilization Ratio fell to 0.06 in Q2 2026 per NRIX's latest filing, from 0.11 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.24 in Q1 2024 and bottomed at 0.06 in Q2 2026.
• Historically, Asset Utilization Ratio has averaged 0.13 across 5 years, with a median of 0.11 in 2024.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio jumped 163.05% — and 2025, when it sank 63.71%.
• Nurix Therapeutics' Asset Utilization Ratio stood at 0.09 in 2022, then surged by 163.05% to 0.23 in 2023, then slumped by 60.24% to 0.09 in 2024, then soared by 50.44% to 0.14 in 2025, then tumbled by 54.77% to 0.06 in 2026.
• Business Quant data shows NRIX's Asset Utilization Ratio at 0.06 in Q2 2026, 0.11 in Q1 2026, and 0.14 in Q4 2025.